Most-favored-nation drug pricing is usually presented as a clever way to make other countries pay their fair share. Americans pay more for the same medicine than Germans, Canadians or the French, so why not simply link US prices to what those countries pay? The problem is that this is not really a trade policy. It is a price control. The only unusual feature is that Washington would… Source
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.